David L. Ashley

8.6k total citations
204 papers, 6.8k citations indexed

About

David L. Ashley is a scholar working on Health, Toxicology and Mutagenesis, Physiology and Cancer Research. According to data from OpenAlex, David L. Ashley has authored 204 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Health, Toxicology and Mutagenesis, 75 papers in Physiology and 35 papers in Cancer Research. Recurrent topics in David L. Ashley's work include Smoking Behavior and Cessation (72 papers), Air Quality and Health Impacts (38 papers) and Carcinogens and Genotoxicity Assessment (35 papers). David L. Ashley is often cited by papers focused on Smoking Behavior and Cessation (72 papers), Air Quality and Health Impacts (38 papers) and Carcinogens and Genotoxicity Assessment (35 papers). David L. Ashley collaborates with scholars based in United States, Australia and China. David L. Ashley's co-authors include Clifford H. Watson, Gregory Polzin, Stephen B. Stanfill, J M McCraw, Joe V. Wooten, Michael A. Bonin, Larry L. Needham, Yan S. Ding, F L Cardinali and Benjamin C. Blount and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

David L. Ashley

194 papers receiving 6.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David L. Ashley United States	50	2.9k	1.9k	1.0k	875	707	204	6.8k
Antonio Mutti Italy	54	3.7k 1.3×	897 0.5×	1.4k 1.3×	1.6k 1.8×	623 0.9×	265	9.4k
Benjamin C. Blount United States	46	4.7k 1.6×	1.5k 0.8×	782 0.8×	1.3k 1.4×	820 1.2×	207	8.9k
Clifford H. Watson United States	43	1.6k 0.6×	1.6k 0.8×	494 0.5×	940 1.1×	335 0.5×	160	5.0k
Peter Fürst Germany	41	2.1k 0.7×	1.2k 0.6×	578 0.6×	833 1.0×	250 0.4×	153	7.4k
Eric J. Sampson United States	40	2.5k 0.9×	594 0.3×	898 0.9×	920 1.1×	533 0.8×	103	6.4k
James L. Pirkle United States	53	7.6k 2.6×	2.0k 1.0×	1.6k 1.5×	1.5k 1.7×	1.1k 1.6×	155	13.0k
Jan Aaseth Norway	58	4.0k 1.4×	915 0.5×	231 0.2×	1.8k 2.1×	532 0.8×	252	11.0k
John T. Bernert United States	49	3.6k 1.3×	3.3k 1.7×	827 0.8×	1.1k 1.3×	1.0k 1.4×	108	8.3k
Dietrich Hoffmann United States	54	2.6k 0.9×	1.9k 1.0×	3.1k 3.0×	3.2k 3.6×	416 0.6×	237	11.0k
Ming‐Tsang Wu Taiwan	53	2.5k 0.9×	446 0.2×	1.2k 1.1×	2.2k 2.5×	414 0.6×	394	10.0k

Countries citing papers authored by David L. Ashley

Since Specialization

Citations

This map shows the geographic impact of David L. Ashley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Ashley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Ashley more than expected).

Fields of papers citing papers by David L. Ashley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David L. Ashley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Ashley. The network helps show where David L. Ashley may publish in the future.

Co-authorship network of co-authors of David L. Ashley

This figure shows the co-authorship network connecting the top 25 collaborators of David L. Ashley. A scholar is included among the top collaborators of David L. Ashley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David L. Ashley. David L. Ashley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Massey, Zachary B., et al.. (2025). Types of electronic nicotine delivery systems (ENDS) used by people of different age and smoking status groups: results from a US nationally representative survey. BMJ Open. 15(2). e087775–e087775.

Nyman, Amy L., Katherine Henderson, Jonathan E. Holland, et al.. (2025). Cross-sectional comparison of sociodemographic and tobacco use characteristics of US adults who regularly use products of leading electronic nicotine delivery systems (ENDS). Tobacco Induced Diseases. 23(December). 1–13.

Yang, Bo, et al.. (2024). Perceptions of a reduced nicotine policy and predictors of policy support: A nationally representative U.S. survey. Preventive Medicine. 184. 107952–107952. 1 indexed citations

Henderson, Katherine, Bo Yang, Hue Trong Duong, et al.. (2024). Independent and combined effects of very low nicotine cigarette messages and e-cigarette messages: a randomised clinical trial. Tobacco Control. 34(e1). e48–e56.

Erinoso, Olufemi, Jennifer Brown, Allison Glasser, et al.. (2024). Evidence-Based Post-Ban Research to Inform Effective Menthol Cigarette Bans in the United States and Other Jurisdictions. Nicotine & Tobacco Research. 26(10). 1434–1437.

Ashley, David L., Wanzhe Zhu, Deepak Bhandari, et al.. (2023). Influence of Half-life and Smoking/Nonsmoking Ratio on Biomarker Consistency between Waves 1 and 2 of the Population Assessment of Tobacco and Health Study. Cancer Epidemiology Biomarkers & Prevention. 33(1). 80–87. 1 indexed citations

O’Connor, Richard J., Liane M. Schneller, Nicholas J. Felicione, et al.. (2022). Evolution of tobacco products: recent history and future directions. Tobacco Control. 31(2). 175–182. 62 indexed citations

Ashley, David L., Wanzhe Zhu, Lanqing Wang, et al.. (2022). Variability in Urinary Nicotine Exposure Biomarker Levels Between Waves 1 (2013–2014) and 2 (2014–2015) in the Population Assessment of Tobacco and Health Study. Nicotine & Tobacco Research. 25(4). 616–623. 1 indexed citations

Carroll, Dana Mowls, Irina Stepanov, Richard J. O’Connor, et al.. (2020). Impact of Cigarette Filter Ventilation on U.S. Smokers' Perceptions and Biomarkers of Exposure and Potential Harm. Cancer Epidemiology Biomarkers & Prevention. 30(1). 38–44. 12 indexed citations

10.

Ashley, David L., et al.. (2020). Urinary Acrylonitrile Metabolite Concentrations Before and after Smoked, Vaporized, and Oral Cannabis in Frequent and Occasional Cannabis Users. International Journal of Environmental Research and Public Health. 17(18). 6438–6438. 8 indexed citations

11.

Hassan, Salah S., et al.. (2020). Social media continuation intention: a contrarian analysis. The Journal of Marketing Theory and Practice. 29(2). 175–188. 4 indexed citations

12.

Geoerger, Birgit, Isabelle Aerts, María José Casanova, et al.. (2012). UPDATED RESULTS FROM A PHASE I STUDY OF LDE225, A SMOOTHENED ANTAGONIST, IN PEDIATRIC PATIENTS WITH RECURRENT MEDULLOBLASTOMA OR OTHER SOLID TUMORS. UCL Discovery (University College London). 4 indexed citations

13.

Ashley, David L., Richard J. O’Connor, John T. Bernert, et al.. (2010). Effect of Differing Levels of Tobacco-Specific Nitrosamines in Cigarette Smoke on the Levels of Biomarkers in Smokers. Cancer Epidemiology Biomarkers & Prevention. 19(6). 1389–1398. 49 indexed citations

14.

Bernert, John T., Sydney M. Gordon, Ram B. Jain, et al.. (2009). Increases in tobacco exposure biomarkers measured in non-smokers exposed to sidestream cigarette smoke under controlled conditions. Biomarkers. 14(2). 82–93. 19 indexed citations

15.

Stanfill, Stephen B., et al.. (2008). Automated determination of seven phenolic compounds in mainstream tobacco smoke. Nicotine & Tobacco Research. 10(7). 1261–1268. 23 indexed citations

16.

Pappas, R. Steven, Gregory Polzin, Clifford H. Watson, & David L. Ashley. (2006). Cadmium, lead, and thallium in smoke particulate from counterfeit cigarettes compared to authentic US brands. Food and Chemical Toxicology. 45(2). 202–209. 73 indexed citations

17.

Ashley, David L., et al.. (1998). Sample purification for the analysis of caffeine in tobacco by gas chromatography–mass spectrometry. Journal of Chromatography A. 814(1-2). 171–180. 11 indexed citations

18.

Driskell, William J., David L. Ashley, James Grainger, et al.. (1992). Identification of decomposition products of 1,1′-ethylidenebis [L-tryptophan], a compound associated with eosinophilia-myalgia syndrome. Bulletin of Environmental Contamination and Toxicology. 48(5). 679–687. 7 indexed citations

19.

Ashley, David L.. (1981). HIGHWAY APPRAISAL UNDER UNCERTAINTY.

20.

Ashley, David L.. (1979). Consultant contract proposals. BMJ. 2(6194). 868.4–869.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact